(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.03%) $0.927
(-0.02%) $10.84
(-0.11%) $0.791
(-0.24%) $92.35
Live Chart Being Loaded With Signals
Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL, a steroid releasing implant to open the surgically enlarged sinus; PROPEL Mini, a releasing implant to treat patients undergoing frontal sinus surgery; and PROPEL Contour, a steroid releasing implant for the treatment of frontal and maxillary sinus ostia, or openings, of the dependent sinuses...
Stats | |
---|---|
Today's Volume | 0.00 |
Average Volume | 438 704 |
Market Cap | 0.00 |
EPS | $-0.850 ( 2022-05-04 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -10.54 |
ATR14 | $0.137 (0.49%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-05-13 | Meier Richard A | Sell | 57 230 | Common Stock |
2022-05-13 | Meier Richard A | Sell | 65 759 | Common Stock |
2022-05-13 | Meier Richard A | Sell | 40 607 | Common Stock |
2022-05-13 | Meier Richard A | Sell | 34 000 | Stock Options (Right to buy) |
2022-05-13 | Meier Richard A | Sell | 74 852 | Stock Options (Right to buy) |
INSIDER POWER |
---|
-100.00 |
Last 98 transactions |
Buy: 482 629 | Sell: 874 745 |
Volume Correlation
Intersect Ent Inc Correlation
10 Most Positive Correlations | |
---|---|
GLLI | 0.937 |
ACAB | 0.933 |
FEXD | 0.929 |
APMI | 0.929 |
FNVT | 0.929 |
AVAC | 0.928 |
CBRG | 0.926 |
CIIG | 0.925 |
BRIV | 0.923 |
ALSA | 0.921 |
10 Most Negative Correlations | |
---|---|
EVLO | -0.925 |
NCBS | -0.923 |
IRBT | -0.922 |
CREG | -0.92 |
DRUG | -0.917 |
ATAI | -0.916 |
CRON | -0.913 |
ARQQ | -0.912 |
BLU | -0.911 |
VFF | -0.91 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Intersect Ent Inc Correlation - Currency/Commodity
Intersect Ent Inc Financials
Annual | 2021 |
Revenue: | $106.75M |
Gross Profit: | $76.74M (71.89 %) |
EPS: | $-4.80 |
Q1 | 2022 |
Revenue: | $21.58M |
Gross Profit: | $13.89M (64.36 %) |
EPS: | $-0.910 |
Q4 | 2021 |
Revenue: | $30.67M |
Gross Profit: | $22.53M (73.47 %) |
EPS: | $-2.73 |
Q3 | 2021 |
Revenue: | $24.40M |
Gross Profit: | $19.31M (79.15 %) |
EPS: | $-0.950 |
Financial Reports:
No articles found.
Intersect Ent Inc
Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL, a steroid releasing implant to open the surgically enlarged sinus; PROPEL Mini, a releasing implant to treat patients undergoing frontal sinus surgery; and PROPEL Contour, a steroid releasing implant for the treatment of frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for the treatment of patients in the physician office setting; VENSURE Navigable and Stand-alone balloon, a sterile and single-use device, used to access and treat frontal, sphenoid sinus, and maxillary ostia in adults using a trans-nasal approach; and CUBE Navigation System, a virtual guidance platform for high precision ENT and ENT related skull-base surgeries. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators